Market News

Pinnacle Foods Del (PF) Holding Maintained by Jana Partners Llc; Progenics Pharmaceuticals In (PGNX) Market Value Rose While Vanguard Group Has Lowered Its Position by $1.51 Million

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Logo

Barry Rosenstein increased its stake in Pinnacle Foods Inc Del (PF) by 23.74% based on its latest 2017Q4 regulatory filing with the SEC. Jana Partners Llc bought 272,723 shares as the company’s stock declined 9.45% with the market. The hedge fund run by Barry Rosenstein held 1.42M shares of the consumer non-durables company at the end of 2017Q4, valued at $84.54 million, up from 1.15M at the end of the previous reported quarter. Jana Partners Llc who had been investing in Pinnacle Foods Inc Del for a number of months, seems to be bullish on the $7.21B market cap company. The stock increased 9.75% or $5.38 during the last trading session, reaching $60.58. About 7.00M shares traded or 264.94% up from the average. Pinnacle Foods Inc. (NYSE:PF) has declined 6.35% since April 22, 2017 and is downtrending. It has underperformed by 17.90% the S&P500.

Vanguard Group Inc decreased its stake in Progenics Pharmaceuticals In (PGNX) by 6.9% based on its latest 2017Q4 regulatory filing with the SEC. Vanguard Group Inc sold 301,421 shares as the company’s stock rose 21.67% while stock markets declined. The institutional investor held 4.07 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $24.21 million, down from 4.37M at the end of the previous reported quarter. Vanguard Group Inc who had been investing in Progenics Pharmaceuticals In for a number of months, seems to be less bullish one the $508.63 million market cap company. The stock decreased 0.28% or $0.02 during the last trading session, reaching $7. About 467,672 shares traded. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has declined 32.66% since April 22, 2017 and is downtrending. It has underperformed by 44.21% the S&P500.

Vanguard Group Inc, which manages about $2286.85 billion US Long portfolio, upped its stake in Eagle Bulk Shipping Inc by 176,787 shares to 1.97M shares, valued at $8.84 million in 2017Q4, according to the filing. It also increased its holding in Tableau Software Inc (NYSE:DATA) by 337,283 shares in the quarter, for a total of 5.39M shares, and has risen its stake in Msci Inc (NYSE:MSCI).

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.11, from 1.11 in 2017Q3. It increased, as 11 investors sold PGNX shares while 40 reduced holdings. 22 funds opened positions while 40 raised stakes. 56.89 million shares or 3.42% less from 58.90 million shares in 2017Q3 were reported. Moreover, Barclays Public Ltd Com has 0% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Westwood Management Il holds 12,000 shares or 0.01% of its portfolio. Hall Laurie J Trustee holds 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) or 620 shares. Blair William And Il stated it has 0% of its portfolio in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Goldman Sachs Grp accumulated 247,970 shares or 0% of the stock. Duncker Streett & Com Inc invested 0.02% of its portfolio in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Arizona State Retirement owns 118,105 shares. Jane Street Grp Ltd Limited Liability Company owns 12,294 shares for 0% of their portfolio. Fmr Ltd invested in 0% or 1.86M shares. 94,652 are owned by Alliancebernstein Ltd Partnership. 44,457 were accumulated by Pub Sector Pension Board. Alps reported 77,867 shares stake. Moreover, Phocas has 0.72% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Teachers Retirement Sys Of The State Of Kentucky owns 24,000 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 2,276 shares.

Analysts await Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) to report earnings on May, 3. They expect $-0.23 EPS, 0.00% or $0.00 from last year’s $-0.23 per share. After $-0.21 actual EPS reported by Progenics Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 9.52% negative EPS growth.

Among 5 analysts covering Progenics Pharm (NASDAQ:PGNX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Progenics Pharm had 11 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was upgraded by Jefferies to “Buy” on Friday, October 23. Zacks downgraded the stock to “Buy” rating in Friday, August 7 report. As per Thursday, October 27, the company rating was initiated by Aegis Capital. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has “Buy” rating given on Wednesday, August 9 by Cantor Fitzgerald. Jefferies maintained it with “Buy” rating and $1200 target in Thursday, June 8 report. The rating was maintained by Brean Capital on Thursday, August 6 with “Buy”. Needham maintained the stock with “Buy” rating in Tuesday, June 20 report. The firm has “Buy” rating by Needham given on Friday, August 7. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) earned “Buy” rating by Jefferies on Tuesday, September 26. The stock has “Strong Buy” rating by Needham on Monday, February 6.

Investors sentiment increased to 1.08 in Q4 2017. Its up 0.26, from 0.82 in 2017Q3. It is positive, as 41 investors sold PF shares while 95 reduced holdings. 57 funds opened positions while 90 raised stakes. 109.66 million shares or 0.76% less from 110.51 million shares in 2017Q3 were reported. Trexquant Inv Lp invested in 0.1% or 15,245 shares. 17,000 were reported by Kbc Grp Nv. Peak6 Invs LP holds 0% or 4,103 shares in its portfolio. Ascend Cap Limited Co holds 0.19% or 83,492 shares in its portfolio. Thrivent For Lutherans, Minnesota-based fund reported 371,765 shares. Hbk Invests LP has 0.14% invested in Pinnacle Foods Inc. (NYSE:PF). Ci Global Investments stated it has 279,930 shares or 0.32% of all its holdings. Channing Capital Limited Com stated it has 185,401 shares. Connor Clark & Lunn Mngmt Limited reported 0.16% in Pinnacle Foods Inc. (NYSE:PF). State Bank Of Montreal Can invested in 0.02% or 434,314 shares. Arrowstreet Cap Limited Partnership owns 112,335 shares or 0.02% of their US portfolio. Moreover, Winfield Associates has 0% invested in Pinnacle Foods Inc. (NYSE:PF). Caisse De Depot Et Placement Du Quebec invested in 125,000 shares. Yorktown Management & Incorporated invested in 0.26% or 15,000 shares. Riverhead Capital Mngmt Limited Liability Co stated it has 20,700 shares.

Among 16 analysts covering Pinnacle Foods Inc (NYSE:PF), 15 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Pinnacle Foods Inc had 43 analyst reports since October 19, 2015 according to SRatingsIntel. The stock of Pinnacle Foods Inc. (NYSE:PF) earned “Buy” rating by UBS on Monday, August 28. The rating was maintained by Buckingham Research on Friday, October 27 with “Buy”. The rating was initiated by Piper Jaffray on Monday, January 9 with “Overweight”. The stock has “Overweight” rating by Morgan Stanley on Friday, March 2. The company was maintained on Friday, October 27 by RBC Capital Markets. Credit Suisse maintained Pinnacle Foods Inc. (NYSE:PF) rating on Wednesday, October 4. Credit Suisse has “Outperform” rating and $64 target. Buckingham Research upgraded it to “Buy” rating and $50 target in Wednesday, March 2 report. The stock of Pinnacle Foods Inc. (NYSE:PF) earned “Buy” rating by Credit Suisse on Wednesday, January 10. The firm has “Buy” rating given on Wednesday, September 6 by BMO Capital Markets. The company was maintained on Friday, March 2 by Credit Suisse.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *